Press "Enter" to skip to content

Johnson & Johnson wins U.S. FDA approval for bladder cancer drug

Johnson & Johnson’s drug Balversa won U.S. approval as the first targeted therapy for advanced bladder cancer, the Food and Drug Administration announced on Friday.

Also Read:   Beaches, parks busy as Europe heat wave and U.S. spring test new coronavirus rules